Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Broadcom reports a surge in AI semiconductor revenue and points to a path beyond $100 billion in AI-chip sales by 202...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Two lesser-known mining names outside China are surging as Pentagon demand and Western reshoring reshape the rare ear...
New filings reveal a surge of political stock trading in Q1, prompting renewed calls for a ban on individual trades b...
Crypto wallets are moving from background helpers to frontline financial services, as wallet makers quiet backbone ex...
A CNN media analyst and The Morning Show producer commend Stephen Colbert for his upbeat farewell, highlighting leade...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...
Rigetti Computing leads a two-day rally in quantum stocks as AI-quantum convergence draws attention from investors an...
A veteran chart analyst warns that XRP is underperforming BTC as dominance tightens, delivering a harsh message to th...
As market conditions shift and living costs rise, households reexamine AD&D policies. This report explains why accide...
SoFi CEO Anthony Noto quietly bought the dip in SOFI stock across four trades this spring. This article breaks down t...